SynthesisPloS one2016

Is Adjuvant Cellular Immunotherapy Essential after TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma? A Systematic Meta-Analysis of Studies Including 1774 Patients.

Min Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.